ArticleFrontiers in cardiovascular medicine2026
Predictors of patient-perceived functional improvement after cardiac resynchronization therapy: a real-world multi-dimensional analysis of clinical, imaging, and ECG predictors.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Up to one-third of appropriately selected patients undergoing cardiac resynchronization therapy (CRT) fail to achieve meaningful clinical benefit despite fulfilling guidelines' criteria. Traditional CRT response definitions [left ventricular (LV) end-systolic volume (ESV), ejection fraction (EF), and QRS duration] frequently diverge and occasionally fail to reflect patient-perceived clinical improvement. Objective: To identify predictors for patient-perceived functional improvement after CRT, incorporating various clinical, biochemical, electrocardiographic (ECG), and imaging variables. Functional improvement was defined as the changes in New York Heart Association (NYHA) functional class 6-9 months after CRT implantation. Methods: This retrospective single-center study included 97 heart failure (HF) patients meeting guideline-based CRT indications. Patients were categorized according to ≥1 NYHA class improvement at 6-9 months. Baseline and follow-up clinical, biochemical, ECG, echocardiographic, and cardiac magnetic resonance (CMR) parameters were compared between groups. Predictors of functional improvement were assessed using univariate and multivariate logistic regression. Results: Sixty-eight patients (70%) achieved ≥1 NYHA class improvement. At baseline, the non-improved group was characterized by higher NT-proBNP and creatinine levels, longer PR and shorter QTc intervals, and worse LV and RV global longitudinal strain (GLS) on CMR. At follow-up, NT-proBNP remained elevated in the non-improved group. Traditional CRT response criteria were more frequently met in the improved compared to the non-improved group (>15% LV ESV reduction: 94.7% vs. 5.3%, >10% LV EF improvement: 98.1% vs. 1.9%, and >20 ms QRS shortening: 86.2% vs. 13.8%); but none independently predicted functional improvement in multivariate analysis. Independent predictors for ≥1 NYHA class improvement included baseline renal function (OR 1.19, 95% CI 1.00-1.39, Conclusion: Functional improvement after CRT is best predicted by multi-dimensional assessment incorporating clinical, biochemical, and imaging parameters. In addition to the traditional response definitions, renal function, LV GLS, and LV diastolic indices were independently associated with a better patient-perceived functional improvement after CRT. Incorporating these factors into CRT eligibility and prognostication may enhance patient selection and improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.